Selection and characterization of single chain Fv fragments against murine recombinant prion protein from a synthetic human antibody phage display library

Human Antibodies

Volumn 9, Issue 4, 2000, Pages 207-214

  Leclerc, Estelle ^a   Liemann, Susanne ^a   Wildegger, Gudrun ^a   Vetter, Stefan W ^a   Nilsson, Fredrik ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV FRAGMENT; PRION PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR RECOGNITION; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; SEQUENCE ANALYSIS;

EID: 0034458844     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2000-9403     Document Type: Article

References (54)

1. Self-replication and scrapie
2. Novel proteinaceous infectious particles cause scrapie
3. Scrapie prions
4. The role of PrP in pathogenesis of experimental scrapie
5. Secondary analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy
6. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity
7. A cellular gene encodes scrapie PrP 27-30 protein
8. Molecular biology of prions diseases
9. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues
10. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
11. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells
12. Genetics of prion infections
13. Prion protein NMR structure and species,barrier for prion diseases
14. Prion protein gene variation among primates
15. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein
16. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins
17. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein
18. Recombinant full-length murine prion protein, mPrP(23-231): Purification and spectroscopic characterization
19. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible
20. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
21. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231)
22. NMR structure of the mouse prion protein domain PrP(121-321)
23. NMR solution structure of the human prion protein
24. The use of monoclonal antibodies in prion disease
25. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril protein
26. Epitope mapping of the syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system
27. Monoclonal antibodies to the cellular and scrapie prion proteins
28. Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein
29. Mapping the prion protein using recombinant antibodies
30. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform
31. Prion (PrPsc)-specific epitope defined by a monoclonal antibody
32. Prion protein expression in different species: Analysis with a panel of new mAbs
33. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion protein and ruminants
34. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein
35. A chicken monoclonal antibody with specificity for the N-terminal of human prion protein
36. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice
37. Design and use of phage display libraries for the selection of antibodies and enzymes
38. Construction and characterization of a set of E. Coil strains deficient in all known loci affecting the proteolytic stability of secreted recombinant proteins
39. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein
40. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain
41. Antibodies from phage display libraries as immunochemical reagents
42. One-step preparation of competent Escherichia Coli: Transformation and storage of bacterial cells in the same solution
43. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with differents hypervariable loops
44. Filamentous fusion phage: Novel expression vectors taht display cloned antigens on the virion surface
45. Phage antibodies: Filamentous phage displaying antibody variable domains
46. Making antibody fragments using phage display libraries
47. By-passing Immunization. Human antibodies from V-gene libraries displayed on phage
48. Antibodies without immunization
49. Antibody fragments from a single pot phage display library as immunochemical reagents
50. Making antibodies by phage-display technology
51. Isolation of high affinity human antibodies directly from large synthetic repertoires
52. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library
53. Mimicking somatic hypermutation: Affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain
54. Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma